Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 29

1.

Design and Optimization of Nanostructured Lipid Carrier Containing Dexamethasone for Ophthalmic Use.

L Kiss E, Berkó S, Gácsi A, Kovács A, Katona G, Soós J, Csányi E, Gróf I, Harazin A, Deli MA, Budai-Szűcs M.

Pharmaceutics. 2019 Dec 14;11(12). pii: E679. doi: 10.3390/pharmaceutics11120679.

2.

Investigation of Silicone-Containing Semisolid in Situ Film-Forming Systems Using QbD Tools.

Kis N, Kovács A, Budai-Szűcs M, Gácsi A, Csányi E, Csóka I, Berkó S.

Pharmaceutics. 2019 Dec 7;11(12). pii: E660. doi: 10.3390/pharmaceutics11120660.

3.

Nanostructured Lipid Carrier Gel for the Dermal Application of Lidocaine: Comparison of Skin Penetration Testing Methods.

Zsikó S, Cutcher K, Kovács A, Budai-Szűcs M, Gácsi A, Baki G, Csányi E, Berkó S.

Pharmaceutics. 2019 Jul 2;11(7). pii: E310. doi: 10.3390/pharmaceutics11070310.

4.

Combination of Zinc Hyaluronate and Metronidazole in a Lipid-Based Drug Delivery System for the Treatment of Periodontitis.

Léber A, Budai-Szűcs M, Urbán E, Vályi P, Gácsi A, Berkó S, Kovács A, Csányi E.

Pharmaceutics. 2019 Mar 25;11(3). pii: E142. doi: 10.3390/pharmaceutics11030142.

5.

Development of Topical Nanocarriers for Skin Cancer Treatment Using Quality by Design Approach.

Csányi E, Bakonyi M, Kovács A, Budai-Szűcs M, Csóka I, Berkó S.

Curr Med Chem. 2019;26(35):6440-6458. doi: 10.2174/0929867325666181116143713. Review.

PMID:
30444194
6.

Papaverine hydrochloride containing nanostructured lyotropic liquid crystal formulation as a potential drug delivery system for the treatment of erectile dysfunction.

Berkó S, Zsikó S, Deák G, Gácsi A, Kovács A, Budai-Szűcs M, Pajor L, Bajory Z, Csányi E.

Drug Des Devel Ther. 2018 Sep 12;12:2923-2931. doi: 10.2147/DDDT.S168218. eCollection 2018.

7.

Electroporation-enhanced transdermal diclofenac sodium delivery into the knee joint in a rat model of acute arthritis.

Hartmann P, Butt E, Fehér Á, Szilágyi ÁL, Jász KD, Balázs B, Bakonyi M, Berkó S, Erős G, Boros M, Horváth G, Varga E, Csányi E.

Drug Des Devel Ther. 2018 Jun 27;12:1917-1930. doi: 10.2147/DDDT.S161703. eCollection 2018.

8.

Following-up skin penetration of lidocaine from different vehicles by Raman spectroscopic mapping.

Bakonyi M, Gácsi A, Kovács A, Szűcs MB, Berkó S, Csányi E.

J Pharm Biomed Anal. 2018 May 30;154:1-6. doi: 10.1016/j.jpba.2018.02.056. Epub 2018 Mar 6.

PMID:
29524770
9.

Mucoadhesive Cyclodextrin-Modified Thiolated Poly(aspartic acid) as a Potential Ophthalmic Drug Delivery System.

Budai-Szűcs M, Kiss EL, Szilágyi BÁ, Szilágyi A, Gyarmati B, Berkó S, Kovács A, Horvát G, Aigner Z, Soós J, Csányi E.

Polymers (Basel). 2018 Feb 16;10(2). pii: E199. doi: 10.3390/polym10020199.

10.

Formulation and Investigation of a Lipid Based Delivery System Containing Antimicrobials for the Treatment of Periodontal Disease.

Leber A, Budai-Szucs M, Urban E, Valyi P, Kovacs A, Berko S, Csanyi E.

Curr Drug Deliv. 2018;15(6):887-897. doi: 10.2174/1567201815666180116092354.

PMID:
29336261
11.

A Review of Electroporation-based Antitumor Skin Therapies and Investigation of Betulinic Acid-loaded Ointment.

Bakonyi M, Berko S, Eros G, Varju G, Dehelean CA, Budai-Szucs M, Csanyi E.

Anticancer Agents Med Chem. 2018;18(5):693-701. doi: 10.2174/1871520617666171113120255. Review.

PMID:
29141562
12.

The effect of the antioxidant on the properties of thiolated poly(aspartic acid) polymers in aqueous ocular formulations.

Budai-Szűcs M, Horvát G, Gyarmati B, Szilágyi BÁ, Szilágyi A, Berkó S, Ambrus R, Szabó-Révész P, Sandri G, Bonferoni MC, Caramella C, Csányi E.

Eur J Pharm Biopharm. 2017 Apr;113:178-187. doi: 10.1016/j.ejpb.2016.12.026. Epub 2017 Jan 11.

PMID:
28088003
13.

Cationic Thiolated Poly(aspartamide) Polymer as a Potential Excipient for Artificial Tear Formulations.

Budai-Szűcs M, Horvát G, Szilágyi BÁ, Gyarmati B, Szilágyi A, Berkó S, Szabó-Révész P, Sandri G, Bonferoni MC, Caramella C, Soós J, Facskó A, Csányi E.

J Ophthalmol. 2016;2016:2647264. doi: 10.1155/2016/2647264. Epub 2016 May 23.

14.

Electroporation-delivered transdermal neostigmine in rats: equivalent action to intravenous administration.

Berkó S, Szűcs KF, Balázs B, Csányi E, Varju G, Sztojkov-Ivanov A, Budai-Szűcs M, Bóta J, Gáspár R.

Drug Des Devel Ther. 2016 May 19;10:1695-701. doi: 10.2147/DDDT.S102959. eCollection 2016.

15.

Development of ibuprofen-loaded nanostructured lipid carrier-based gels: characterization and investigation of in vitro and in vivo penetration through the skin.

Sütő B, Berkó S, Kozma G, Kukovecz Á, Budai-Szűcs M, Erős G, Kemény L, Sztojkov-Ivanov A, Gáspár R, Csányi E.

Int J Nanomedicine. 2016 Mar 30;11:1201-12. doi: 10.2147/IJN.S99198. eCollection 2016.

16.

Investigation of the Efficacy of Transdermal Penetration Enhancers Through the Use of Human Skin and a Skin Mimic Artificial Membrane.

Balázs B, Vizserálek G, Berkó S, Budai-Szűcs M, Kelemen A, Sinkó B, Takács-Novák K, Szabó-Révész P, Csányi E.

J Pharm Sci. 2016 Mar;105(3):1134-40. doi: 10.1016/S0022-3549(15)00172-0. Epub 2016 Jan 25.

PMID:
26886318
17.

ATR-FTIR and Raman spectroscopic investigation of the electroporation-mediated transdermal delivery of a nanocarrier system containing an antitumour drug.

Balázs B, Sipos P, Danciu C, Avram S, Soica C, Dehelean C, Varju G, Erős G, Budai-Szűcs M, Berkó S, Csányi E.

Biomed Opt Express. 2015 Dec 8;7(1):67-78. doi: 10.1364/BOE.7.000067. eCollection 2016 Jan 1.

18.

In vitro testing of thiolated poly(aspartic acid) from ophthalmic formulation aspects.

Budai-Szű Cs M, Horvát G, Gyarmati B, Szilágyi BÁ, Szilágyi A, Csihi T, Berkó S, Szabó-Révész P, Mori M, Sandri G, Bonferoni MC, Caramella C, Csányi E.

Drug Dev Ind Pharm. 2016 Aug;42(8):1241-6. doi: 10.3109/03639045.2015.1118497. Epub 2015 Dec 7.

PMID:
26556306
19.

Comparative study of nanosized cross-linked sodium-, linear sodium- and zinc-hyaluronate as potential ocular mucoadhesive drug delivery systems.

Horvát G, Budai-Szűcs M, Berkó S, Szabó-Révész P, Soós J, Facskó A, Maroda M, Mori M, Sandri G, Bonferoni MC, Caramella C, Csányi E.

Int J Pharm. 2015 Oct 15;494(1):321-8. doi: 10.1016/j.ijpharm.2015.08.024. Epub 2015 Aug 28.

PMID:
26319587
20.

The Effect of Electroporation of a Lyotroic Liquid Crystal Genistein-Based Formulation in the Recovery of Murine Melanoma Lesions.

Danciu C, Berkó S, Varju G, Balázs B, Kemény L, Németh IB, Cioca A, Petruș A, Dehelean C, Cosmin CI, Amaricai E, Toma CC.

Int J Mol Sci. 2015 Jul 8;16(7):15425-41. doi: 10.3390/ijms160715425.

Supplemental Content

Loading ...
Support Center